Zobrazeno 1 - 10
of 434
pro vyhledávání: '"Adult growth hormone deficiency"'
Autor:
Xiaonan Guo, Shanshan Liu, Wenjing Hu, Xiaorui Lyu, Hanyuan Xu, Huijuan Zhu, Hui Pan, Linjie Wang, Yu Wan, Hongbo Yang, Fengying Gong
Publikováno v:
BMC Musculoskeletal Disorders, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Adult growth hormone deficiency (AGHD) is associated with an increased risk of fractures and impaired bone microstructure. Understanding the metabolic changes accompanying bone deterioration in AGHD might provide insights into mec
Externí odkaz:
https://doaj.org/article/26235916443445b5aa6e27b102c36626
Autor:
Kevin C. J. Yuen, Rikke Hjortebjerg, Ashok Ainkaran Ganeshalingam, David R. Clemmons, Jan Frystyk
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Growth hormone (GH) is the key regulator of insulin-like growth factor I (IGF-I) generation in healthy states. However, portal insulin delivery is also an essential co-player in the regulation of the GH/IGF-I axis by affecting and regulating hepatic
Externí odkaz:
https://doaj.org/article/56562f1fe86146629b2fb6d5a7e535dc
Autor:
Sherwin Criseno, Helena Gleeson, Andrew A Toogood, Neil Gittoes, Anne Topping, Niki Karavitaki
Publikováno v:
Endocrine Connections, Vol 13, Iss 5, Pp 1-10 (2024)
Objective: We conducted a survey of UK endocrine clinicians between June 2022 and August 2022 to understand current practices regarding GH treatment discontinuation in adults with growth hormone deficiency. Design and methods: Using Survey Monkey®,
Externí odkaz:
https://doaj.org/article/1f03acc031574d88bfc35d1c264a603b
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 18, Pp 291-306 (2024)
Bradley S Miller,1 Jo Blair,2 Reiko Horikawa,3 Agnès Linglart,4– 7 Kevin CJ Yuen8 1Division of Pediatric Endocrinology, University of Minnesota Medical School, MHealth Fairview Masonic Children’s Hospital, Minneapolis, MN, USA; 2Department of Pa
Externí odkaz:
https://doaj.org/article/0214bae3491f403ead5e55f7a37334a9
Autor:
Balázs Ratku, Hajnalka Lőrincz, Sára Csiha, Veronika Sebestyén, Eszter Berta, Miklós Bodor, Endre V. Nagy, Zoltán Szabó, Mariann Harangi, Sándor Somodi
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionAdult growth hormone deficiency (AGHD) is associated with a high prevalence of metabolic syndrome (MS), which contributes to the unfavorable cardiovascular risk profile in these patients. Insulin like growth factor-1 (IGF-1) is a widely u
Externí odkaz:
https://doaj.org/article/b8d908c1484f41ff9108f8ab56137316
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Martin Bidlingmaier, Beverly M.K. Biller, David Clemmons, Jens Otto L. Jørgensen, Hiroshi Nishioka, Yutaka Takahashi
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/7671dc9111c045bfb0254559001ea363
Autor:
Martin Bidlingmaier, Beverly M.K. Biller, David Clemmons, Jens Otto L. Jørgensen, Hiroshi Nishioka, Yutaka Takahashi
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Adult growth hormone deficiency (AGHD) is a rare endocrine disorder characterized by an abnormal body composition, metabolic abnormalities associated with increased cardiovascular diseases, bone loss, and impaired quality of life. Daily subcutaneous
Externí odkaz:
https://doaj.org/article/342be24d33884ae4b11fbb92d31b1fed
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jose M Garcia, Beverly M K Biller, Márta Korbonits, Vera Popovic, Anton Luger, Christian J Strasburger, Philippe Chanson, Ronald Swerdloff, Christina Wang, Rosa Rosanna Fleming, Fredric Cohen, Nicola Ammer, Gilbert Mueller, Nicky Kelepouris, Frank Strobl, Vlady Ostrow, Kevin C J Yuen
Publikováno v:
Endocrine Connections, Vol 10, Iss 1, Pp 76-83 (2021)
Objective: The macimorelin test is approved for the diagnosis of adult growth hormone deficiency (AGHD) based on its efficacy vs the insulin tolerance t est (ITT). Macimorelin has a significant advantage over ITT in avoiding hypoglycemia. A nalyses w
Externí odkaz:
https://doaj.org/article/cdaf660e6db34106934ef0032fb07ae0